Cambridge Innovation Capital (CIC) has raised £150 million ($196 million) to invest in startups emerging from a UK life sciences research hot spot. The financing will support existing portfolio companies such as Bicycle and Carrick Therapeutics and equip CIC to back additional businesses. Source: Fierce Biotech 1/4/2019